Argenx Immune Disorder Drug's Reach Could Get Much Bigger With Major Trial Win

cryptocurrency 4 hours ago
Flipboard
Argenx advances Vyvgart with strong trial data in seronegative gMG, driving growth projections and reinforcing its leadership in IgG-driven …
Read Entire Article